Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,411 across all filing types
Latest filing 2023-03-22 AGM Information
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
FORM 6-K
AGM Information Classification · 95% confidence The document is a Form 6-K filed with the SEC by AstraZeneca PLC, which is a report of a foreign issuer pursuant to the Securities Exchange Act of 1934. The content includes a detailed Notice of Annual General Meeting (AGM) for 2023, including the agenda items such as receiving the Annual Report and Form 20-F for the year ended 31 December 2022, election and re-election of directors, remuneration report, political donations, allotment of new shares, and pre-emption rights. The document is primarily focused on the AGM notice and related shareholder circular information, including proxy forms and voting instructions. It is not the Annual Report itself, nor is it a financial report or earnings release. The document is lengthy (15,000 characters) and contains substantive AGM-related information, including resolutions to be voted on at the AGM. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2023-03-22 English
Proxy Form for 2023 AGM
AGM Information Classification · 99% confidence The document explicitly contains an 'Attendance Card' and a 'Proxy Form' for the 'Annual General Meeting (AGM)' of AstraZeneca PLC, scheduled for 'Thursday 27 April 2023'. The content details how to attend, how to appoint a proxy, and lists the resolutions to be voted upon at the AGM (including receiving accounts, reappointing auditors, electing directors, and approving remuneration). This material is directly related to soliciting shareholder votes and providing information for the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R). It is not a DEF 14A (Remuneration Report) because it is the voting mechanism, nor is it a 10-K (Annual Report) as it is the meeting material itself.
2023-03-22 English
Marked up version of proposed new Articles to be considered by shareholders at the Annual General Meeting on 27 April 2023
Governance Information Classification · 99% confidence The document is titled 'ARTICLES OF ASSOCIATION OF ASTRAZENECA PLC' and is governed by 'THE COMPANIES ACT 2006'. Articles of Association define the internal rules, governance structure, and operational procedures for a company, including share capital rights (like Redeemable Preference Shares) and meeting procedures. This content directly aligns with the definition of Governance Information (CGR), which covers internal rules and board structure, rather than a financial report (10-K, IR), a management discussion (MDA), or a specific announcement (ER, DIV, etc.). The document length is substantial (over 220,000 characters), confirming it is a foundational document, not a brief announcement.
2023-03-22 English
Publication of proposed new Articles to be considered by shareholders at the Annual General Meeting on 27 April 2023
Governance Information Classification · 98% confidence The document text consists of the full 'ARTICLES OF ASSOCIATION' for 'ASTRAZENECA PLC', detailing the company's internal rules, definitions (like 'Act', 'director', 'share'), and specific rights attached to different share classes (e.g., Redeemable Preference Shares). This content is foundational corporate governance documentation, not a periodic financial report (like 10-K or IR), an announcement (like ER or RPA), or a transcript. Among the provided codes, 'Governance Information' (CGR) is the most appropriate classification for Articles of Association, as they define the company's internal rules and structure.
2023-03-22 English
AGM Notice of Meeting
AGM Information Classification · 100% confidence The document is explicitly titled "Notice of AGM" and contains a "Letter from the Chair" addressed to shareholders regarding the "Annual General Meeting of the Company to be held on Thursday 27 April 2023 (AGM)". It details the resolutions to be voted upon, including the reappointment of the auditor, election of directors, approval of the Remuneration Report, and authority for share allotment. This content is characteristic of materials distributed to shareholders in advance of an Annual General Meeting, which falls under the AGM Information category.
2023-03-22 English
NOTICE OF AGM
AGM Information Classification · 100% confidence The document is a Form 6-K filing by AstraZeneca PLC, which includes a Notice of Annual General Meeting (AGM) scheduled for 27 April 2023. The text explicitly states it is a 'Notice of AGM' and details the agenda items for the meeting, such as receiving accounts, reappointing auditors, electing directors, and approving remuneration reports. It also mentions the publication of the Annual Report separately, indicating this document is not the Annual Report itself but the notice for the AGM. The document length is 5366 characters, which is sufficient to contain the full notice rather than just a brief announcement. Therefore, the document fits the category of AGM Information (AGM-R).
2023-03-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.